ACST - Acasti Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $22.21. This is a potential upside of $18.84 (559.05%) from yesterday's end of day stock price of $3.37.

Acasti Pharma's activity chart (see below) currently has 12 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30% with an average time for these price targets to be met of 32.8 days.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 25-Sep-2024. First documented stock forecast 08-Jul-2019.

Best performing analysts who are covering ACST - Acasti Pharma:

Leland Gershell Mayank Mamtani Constantine Davides Oren Livnat Nathan Weinstein

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$12

$8.63 (256.08%)

$12

1 years 29 days ago
(25-Sep-2024)

0/2 (0%)

$8.93 (290.88%)

Buy

$2.5

$-0.28 (-10.07%)

2 years 8 months 10 days ago
(15-Feb-2023)

1/1 (100%)

$1.86 (290.63%)

145

Buy

$30

3 years 4 months 3 days ago
(21-Jun-2022)

0/2 (0%)

$22.32 (290.63%)

Hold

$12

$8.63 (256.08%)

5 years 1 months 23 days ago
(01-Sep-2020)

1/2 (50%)

$1.58 (15.16%)

19

Buy

5 years 1 months 24 days ago
(30-Aug-2020)

0/1 (0%)

$59.52 (163.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACST (Acasti Pharma) average time for price targets to be met?

On average it took 32.8 days on average for the stock forecasts to be realized with a an average price target met ratio 30

Which analyst has the current highest performing score on ACST (Acasti Pharma) with a proven track record?

LELAND GERSHELL

Which analyst has the current lower performing score on ACST (Acasti Pharma) with a proven track record?

NATHAN WEINSTEIN

Which analyst has the most public recommendations on ACST (Acasti Pharma)?

Leland Gershell works at OPPENHEIMER and has 23 price targets and 11 ratings on ACST

Which analyst is the currently most bullish on ACST (Acasti Pharma)?

Nathan Weinstein with highest potential upside - $8.63

Which analyst is the currently most reserved on ACST (Acasti Pharma)?

Constantine Davides with lowest potential downside - -$0.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?